Latest filing published 10 Nov 2021 for ViewRay, Inc., €24.3M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +50.2%Entry US$2.91 · Close at T+365 US$4.37
- +47.5%Entry US$2.99 · Close at T+365 US$4.41
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fosun International Ltd: trading record in brief
Fosun International Ltd discloses dealings in 2 companies, chiefly ViewRay, Inc. and Amneal Pharmaceuticals, Inc. In total, 8 filings cover trades dated from 21 May 2018 to 8 November 2021.
In open-market terms, that means 5 purchases worth €47.4M on one side and 2 sales worth €45.4M on the other. On balance, insiders were net buyers of €2.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2021 alone, the filings show no purchases and 2 sales.
The median purchase comes to €4.5M. Clusters matter here: 4 out of 5 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 10 November 2021 came the latest disclosure, an open-market sale for €24.3M in ViewRay, Inc. The most recent open-market purchase was published on 10 December 2019, 2,526 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Fosun International Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000,000 shares@ US$7.0253.5% of flowCommon StockSEC:0001104659-21-136572:0
- 4,300,000 shares@ US$5.9746.5% of flowCommon StockSEC:0001104659-21-079091:0
- 1,597,444 shares@ US$3.135.3% of flowCommon StockSEC:0001104659-19-071330:1Canonical exit: 5 Mar 2020 (T+90)
- 5,750,798 shares@ US$3.1319.2% of flowCommon StockSEC:0001104659-19-071330:0Canonical exit: 5 Mar 2020 (T+90)
- 327,000 shares@ US$2.9116.1% of flowClass A Common StockSEC:0001144204-19-038365:0Canonical exit: 4 Nov 2019 (T+90)
- 1,642,300 shares@ US$3.0483.9% of flowClass A Common StockSEC:0001144204-19-038060:0Canonical exit: 3 Nov 2019 (T+90)
- 2,702,702 shares@ US$9.2525.4% of flowCommon StockSEC:0001144204-18-047548:0Canonical exit: 28 Nov 2018 (T+90)
- 3,000,581 shares@ US$8.3125.1% of flowCommon StockSEC:0001144204-18-047548:1
8 of 6 declarations
